Dr. Dent is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
20 Duke Medicine Cir
Durham, NC 27710Phone+1 919-613-4077Fax+1 919-613-4077- Is this information wrong?
Education & Training
Michael G. DeGroote School of MedicineClass of 1990
Certifications & Licensure
NC State Medical License 2018 - 2024
Clinical Trials
- Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477) Start of enrollment: 2020 Nov 13
- STOP-HER2: Stopping Trastuzumab in HER2+ MBC Start of enrollment: 2023 Apr 19
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Use of new and emerging cancer drugs: what the cardiologist needs to know.Iacopo Fabiani, Michela Chianca, Alberto Aimo, Michele Emdin, Antonella Fedele, Carlo Maria Cipolla, Daniela Maria Cardinale, Susan Dent> ;European Heart Journal. 2024 Apr 9
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique.Emily J Gallagher, Heather Moore, Mario E Lacouture, Susan F Dent, Azeez Farooki, Marcus D Goncalves, Claudine Isaacs, Abigail Johnston, Dejan Juric, Zoe Quandt, Laura...> ;NPJ Breast Cancer. 2024 Jan 31
- Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings:State-of-the-Art Review.Salloum, F., Tocchetti, C., Ameri, P., Ardehali, H., Asnani, A., de Boer, R., Burridge, P., Cabrera, J., de Castro, J., Córdoba, R., Costa, A., Dent, S., Engelbertsen,...> ;JACC. Cardiooncology. 2023 Dec 1
- Join now to see all
Authored Content
- Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast CancerDecember 2022
Press Mentions
Atrium Health Receives Grant to Help Researchers Uncover Signs of Heart Damage in Breast Cancer SurvivorsJuly 7th, 2022- Professor Receives Grant to Develop Breast Cancer Therapy That Combats Drug ResistanceSeptember 20th, 2021
- PREFECT Trial Outcomes Demonstrate MyoStrain® Ability to Detect & Predict Early Cardiotoxicity in Cancer Patients Undergoing ChemotherapyJune 23rd, 2021
- Join now to see all
Hospital Affiliations
Duke University HospitalDurham, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
